Biodesix, Inc. (BDSX)
9.88
+0.09
(+0.92%)
USD |
NASDAQ |
Nov 13, 16:00
9.96
+0.08
(+0.81%)
After-Hours: 19:59
Biodesix Shareholders Equity (Quarterly) : 8.675M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 8.675M |
| June 30, 2026 | 9.144M |
| March 31, 2026 | 9.132M |
| December 31, 2025 | -2.465M |
| September 30, 2025 | -1.722M |
| June 30, 2025 | 1.138M |
| March 31, 2025 | 11.06M |
| December 31, 2024 | 20.88M |
| September 30, 2024 | 27.86M |
| June 30, 2024 | 36.26M |
| March 31, 2024 | -5.502M |
| December 31, 2023 | 4.58M |
| September 30, 2023 | -1.446M |
| June 30, 2023 | -6.993M |
| Date | Value |
|---|---|
| March 31, 2023 | 4.55M |
| December 31, 2022 | 20.61M |
| September 30, 2022 | -2.903M |
| June 30, 2022 | 7.671M |
| March 31, 2022 | 7.781M |
| December 31, 2021 | 19.73M |
| September 30, 2021 | 16.03M |
| June 30, 2021 | 25.77M |
| March 31, 2021 | 36.43M |
| December 31, 2020 | 41.17M |
| September 30, 2020 | -255.18M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -228.54M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BillionToOne, Inc. | 566.55M |
| Quest Diagnostics, Inc. | 7.632B |
| Labcorp Holdings, Inc. | 8.848B |
| OPKO Health, Inc. | 1.116B |
| Psychemedics Corp. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 93.94M |
| Total Liabilities (Quarterly) | 85.27M |
| Debt to Equity Ratio | 8.350 |
| Current Ratio | 2.957 |
| Net Debt Paydown Yield | -0.02% |